Inhibiting corrosion and side reactions of zinc metal anode by nano-CaSiO3coating towards high-performance aqueous zinc-ion batteries.

The aqueous Zn-ion batteries (AZIBs) have been deemed as one of the most promising energy storage devices owing to their high safety, low cost, and environmental benignity. Nevertheless, the severe corrosion of zinc metal anode and side reactions between the anode and electrolyte greatly hinder the practical application of AZIBs. To address above-mentioned issues, herein, a nano-CaSiO3layer was coated on the surface of Zn metal anode via the solution casting method. Results showed that this hydrophobic coating layer could effectively inhibit the direct contact of Zn metal anode with electrolyte, suppressing its corrosion and side reactions during Zn deposition/stripping. When applied in symmetrical cells, the nano-CaSiO3coated Zn (CSO-Zn) electrode exhibited much longer cycle life than bare Zn electrode. Moreover, with this nano-CaSiO3modified Zn anode, both vanadium-based and manganese-based full cells depicted excellent capacity retention. This nano-CaSiO3coating layer provides a good choice for improving the stability of Zn metal anode for high-performance AZIBs.

Preparation of Hollow Core-Shell Fe3O4/Nitrogen-Doped Carbon Nanocomposites for Lithium-Ion Batteries.

Iron oxides are potential electrode materials for lithium-ion batteries because of their high theoretical capacities, low cost, rich resources, and their non-polluting properties. However, iron oxides demonstrate large volume expansion during the lithium intercalation process, resulting in the electrode material being crushed, which always results in poor cycle performance. In this paper, to solve the above problem, iron oxide/carbon nanocomposites with a hollow core-shell structure were designed. Firstly, an Fe2O3@polydopamine nanocomposite was prepared using an Fe2O3 nanocube and dopamine hydrochloride as precursors. Secondly, an Fe3O4@N-doped C composite was obtained by means of further carbonization treatment. Finally, Fe3O4@void@N-Doped C-x composites with core-shell structures with different void sizes were obtained by means of Fe3O4 etching. The effect of the etching time on the void size was studied. The electrochemical properties of the composites when used as lithium-ion battery materials were studied in more detail. The results showed that the sample that was obtained via etching for 5 h using 2 mol L-1 HCl solution at 30 °C demonstrated better electrochemical performance. The discharge capacity of the Fe3O4@void@N-Doped C-5 was able to reach up to 1222 mA g h-1 under 200 mA g-1 after 100 cycles.

Artesunate ameliorates cigarette smoke-induced airway remodelling via PPAR-γ/TGF-ß1/Smad2/3 signalling pathway.

BACKGROUND: Airway remodelling is the major pathological feature of chronic obstructive pulmonary disease (COPD), and leads to poorly reversible airway obstruction. Current pharmacological interventions are ineffective in controlling airway remodelling. In the present study, we investigated the potential role of artesunate in preventing and treating airway remodelling and the underlying molecular mechanisms in vitro and in vivo. METHODS: A COPD rat model was established by cigarette smoke (CS) exposure. After 12 weeks of artesunate treatment, pathological changes in the lung tissues of COPD rats were examined by ELISA and histochemical and immunohistochemical staining. A lung functional experiment was also carried out to elucidate the effects of artesunate. Human bronchial smooth muscle (HBSM) cells were used to clarify the underlying molecular mechanisms. RESULTS: Artesunate treatment inhibited CS-induced airway inflammation and oxidative stress in a dose-dependent manner and significantly reduced airway remodelling by inhibiting α-smooth muscle actin (α-SMA) and cyclin D1 expression. PPAR-γ was upregulated and TGF-ß1/Smad2/3 signalling was inactivated by artesunate treatment in vivo and in vitro. Furthermore, PPAR-γ knockdown by siRNA transfection abolished artesunate-mediated inhibition of HBSM cell proliferation by activiting the TGF-ß1/Smad2/3 signalling pathway and downregulating the expression of α-SMA and cyclin D1 in HBSM cells. CONCLUSIONS: These findings suggest that artesunate could be used to treat airway remodelling by regulating PPAR-γ/TGF-ß1/Smad signalling in the context of COPD.

Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials.

INTRODUCTION: Many concerns still exist regarding the safety of hydroxychloroquine (HCQ) in the treatment of Coronavirus Disease 2019 (COVID-19). OBJECTIVES: The purpose of this study was to evaluate the safety of HCQ in the treatment of COVID-19 and other diseases by performing a systematic review and meta-analysis. METHODS: Randomized controlled trials (RCTs) reporting the safety of HCQ in PubMed, Embase, and Cochrane Library were retrieved starting from the establishment of the database till June 5, 2020. Literature screening, data extraction, and assessment of risk bias were performed independently by two reviewers. RESULTS: We identified 53 eligible studies involving 5496 patients. The meta-analysis indicated that the risk of adverse effects (AEs) in the HCQ group was significantly increased compared with that in the control group (RD 0.05, 95%CI, 0.02 to 0.07, P = 0.0002), and the difference was also statistically significant in the COVID-19 subgroup (RD 0.15, 95%CI, 0.07 to 0.23, P = 0.0002) as well as in the subgroup for other diseases (RD 0.03, 95%CI, 0.01 to 0.04, P = 0.003). CONCLUSIONS: HCQ is associated with a high total risk of AEs compared with the placebo or no intervention in the overall population. Given the small number of COVID-19 participants included, we should be cautious regarding the conclusion stating that HCQ is linked with an increase incidence of AEs in patients with COVID-19, which we hope to confirm in the future through well-designed and larger sample size studies.

Hatted 1T/2H-Phase MoS2 on Ni3 S2 Nanorods for Efficient Overall Water Splitting in Alkaline Media.

A new hatted 1T/2H-phase MoS2 on Ni3 S2 nanorods, as a bifunctional electrocatalyst for overall water splitting in alkaline media, is prepared through a simple one-pot hydrothermal synthesis. The hat-rod structure is composed mainly of Ni3 S2 , with 1T/2H-MoS2 adhered to the top of the growth. Aqueous ammonia plays an important role in forming the 1T-phase MoS2 by twisting the 2H-phase transition and expanding the interlayer spacing through the intercalation of NH3 /NH4 + . Owing to the special "hat-like" structure, the electrons conduct easily from Ni foam along Ni3 S2 to MoS2 , and the catalyst particles maintain sufficient contact with the electrolyte, with gaseous molecules produced by water splitting easily removed from the surface of the catalyst. Thus, the electrocatalytic performance is enhanced, with an overpotential of 73 mV, a Tafel slope of 79 mV dec-1 , and excellent stability, and the OER demonstrates an overpotential of 190 mV and Tafel slope of 166 mV dec-1 .

Vancomycin-induced acute kidney injury in elderly Chinese patients: a single-centre cross-sectional study.

AIMS: The objective of the present study was to investigate the current situation concerning, and risk factors for, vancomycin (VAN)-induced acute kidney injury (VI-AKI) in elderly Chinese patients, to assess outcomes and risk factors in patients who have developed VI-AKI, in order to provide suggestions for improving the prevention and treatment of this condition in these patients. METHOD: We retrospectively identified elderly older inpatients who had received four or more doses of VAN treatment. We compared patients with VI-AKI with those who received VAN treatment and had not developed AKI (NO-AKI). We defined VI-AKI as developing AKI during VAN therapy or within 3 days after withdrawal of VAN. RESULTS: A total of 647 out of 862 elderly inpatients were included in the study. Among those excluded, in 89.3% of cases (192/215) this was because of lack of data on serum creatinine (SCr). Among included patients, 32.5% (210/647) of patients received therapeutic drug monitoring (TDM) during VAN therapy. In 66.9% of cases (424/634), there was insufficient TDM, and in 3.9% (25/634) this was appropriate. A total of 102 patients had confirmed VI-AKI, with an incidence of 15.8% (102/647). Multiple logistic regression analysis revealed that hyperuricaemia [odds ratio (OR) = 3.045; P = 0.000)], mechanical ventilation (OR = 1.906; P = 0.022) and concomitant vasopressor therapy (OR = 1.919; P = 0.027) were independent risk factors for VI-AKI; higher serum albumin (OR = 0.885; P = 0.000) was determined to be an independent protective factor for VI-AKI. CONCLUSIONS: For the elderly Chinese patients treated with VAN, there was insufficient monitoring of SCr, too little use of VAN TDM, and lower rate of patients whose VAN though serum concentrations were not obtained at the correct time. We recommend that hospital managers increase investment in clinical pharmacists, to strengthen professional management. Patients with concomitant hyperuricaemia and on mechanical ventilation and vasopressor therapy should be paid more attention, and a higher serum albumin was determined to be an independent protective factor for VI-AKI.

Heterojunction tunnelled vanadium-based cathode materials for high-performance aqueous zinc ion batteries.

Rechargeable aqueous zinc ion batteries (ZIBs) have emerged as a promising alternative to lithium-ion batteries due to their inherent safety, abundant availability, environmental friendliness and cost-effectiveness. However, the cathodes in ZIBs encounter challenges such as structural instability, low capacity, and sluggish kinetics. In this study, we constructed BiVO4@VO2 (BVO@VO) heterojunction cathode material with bismuth vanadate and vanadium dioxide phases for ZIBs, which demonstrate significant advancements in both aqueous and quasi-solid-state ZIBs. Benefitting from the heterojunction structure, the materials present a high capacity of 262 mAh g-1 at 0.1 A g-1, superb cyclic stability with 96% capacity retention after 1000 cycles at 2 A g-1, and outstanding rate property with a specific capacity of 218 mAh g-1 even at a high rate of 5.0 A g-1. Furthermore, the flexible quasi-solid-state ZIBs incorporating the BVO@VO cathode demonstrate prolonged cyclic life performance with a remarkable specific capacity of 234 mAh g-1 over 100 cycles at a current density of 0.1 A g-1. This study potentially paves the way for the utilization of heterointerface-enhanced zinc ion diffusion for vanadium-based materials in ZIBs, thereby providing a new approach for the design and investigation of high-performance zinc-ion systems.

Soluble interleukin-2 receptor combined with interleukin-8 is a powerful predictor of future adverse cardiovascular events in patients with acute myocardial infarction.

Background: Little is known about the role of interleukin (IL) in patients with acute myocardial infarction (MI), especially soluble IL-2 receptor (sIL-2R) and IL-8. We aim to evaluate, in MI patients, the predictive value of serum sIL-2R and IL-8 for future major adverse cardiovascular events (MACEs), and compare them with current biomarkers reflecting myocardial inflammation and injury. Methods: This was a prospective, single-center cohort study. We measured serum concentrations of IL-1ß, sIL-2R, IL-6, IL-8 and IL-10. Levels of current biomarkers for predicting MACEs were measured, including high-sensitivity C reactive protein, cardiac troponin T and N-terminal pro-brain natriuretic peptide. Clinical events were collected during 1-year and a median of 2.2 years (long-term) follow-up. Results: Twenty-four patients (13.8%, 24/173) experienced MACEs during 1-year follow-up and 40 patients (23.1%, 40/173) during long-term follow-up. Of the five interleukins studied, only sIL-2R and IL-8 were independently associated with endpoints during 1-year or long-term follow-up. Patients with high sIL-2R or IL-8 levels (higher than the cutoff value) had a significantly higher risk of MACEs during 1-year (sIL-2R: HR 7.7, 3.3-18.0, p < 0.001; IL-8: HR 4.8, 2.1-10.7, p < 0.001) and long-term (sIL-2R: HR 7.7, 3.3-18.0, p < 0.001; IL-8: HR 4.8, 2.1-10.7, p < 0.001) follow-up. Receiver operator characteristic curve analysis regarding predictive accuracy for MACEs during 1-year follow-up showed that the area under the curve for sIL-2R, IL-8, sIL-2R combined with IL-8 was 0.66 (0.54-0.79, p = 0.011), 0.69 (0.56-0.82, p < 0.001) and 0.720 (0.59-0.85, p < 0.001), whose predictive value were superior to that of current biomarkers. The addition of sIL-2R combined with IL-8 to the existing prediction model resulted in a significant improvement in predictive power (p = 0.029), prompting a 20.8% increase in the proportion of correct classifications. Conclusions: High serum sIL-2R combined with IL-8 levels was significantly associated with MACEs during follow-up in patients with MI, suggesting that sIL-2R combined with IL-8 may be a helpful biomarker for identifying the increased risk of new cardiovascular events. IL-2 and IL-8 would be promising therapeutic targets for anti-inflammatory therapy.

Dual CoxSy-Modified Tungsten Disulfide Double-Heterojunction Electrocatalyst for Efficient Hydrogen Evolution in All-pH Media.

The rational design and preparation of a heterogeneous electrocatalyst for hydrogen evolution reaction (HER) has become a research hotspot, while applicable and pH-universal tungsten disulfide (WS2)-based hybrid composites are rarely reported. Herein, we propose a novel hybrid catalyst (WS2/Co9S8/Co4S3) comprising two heterojunctions of WS2/Co4S3 and WS2/Co9S8, which grow on the porous skeleton of Co, N-codoped carbon (Co/NC) flexibly applicable to all-pH electrolytes. The effect of double heterogeneous coupling on HER activity is explored as the highly flexible heterojunction is conducive to tune the activity of the catalyst, and the synergistic interaction of the double heterojunctions is maximized by adjusting the proportion of heterojunction components. Theoretical calculations show that both WS2/Co9S8 and WS2/Co4S3 heterojunctions have a Gibbs free energy of H reaction (|ΔGH*|) close to 0.0 eV and a facile decomposition water barrier. As collective synergy of dual CoxSy-modified WS2 double heterojunction, WS2/Co9S8/Co4S3 greatly enhances HER activity compared to bare Co9S8/Co4S3 or single heterojunction (WS2/Co9S8) in all-pH media. Besides, we have elucidated the unique HER mechanism of the double heterojunction to decompose H2O and confirm its excellent activity under alkaline and neutral conditions. Thus, this work provides new insights into WS2-based hybrid materials potentially applied to sustainable energy.

Machine Learning-Assisted Low-Dimensional Electrocatalysts Design for Hydrogen Evolution Reaction.

Efficient electrocatalysts are crucial for hydrogen generation from electrolyzing water. Nevertheless, the conventional "trial and error" method for producing advanced electrocatalysts is not only cost-ineffective but also time-consuming and labor-intensive. Fortunately, the advancement of machine learning brings new opportunities for electrocatalysts discovery and design. By analyzing experimental and theoretical data, machine learning can effectively predict their hydrogen evolution reaction (HER) performance. This review summarizes recent developments in machine learning for low-dimensional electrocatalysts, including zero-dimension nanoparticles and nanoclusters, one-dimensional nanotubes and nanowires, two-dimensional nanosheets, as well as other electrocatalysts. In particular, the effects of descriptors and algorithms on screening low-dimensional electrocatalysts and investigating their HER performance are highlighted. Finally, the future directions and perspectives for machine learning in electrocatalysis are discussed, emphasizing the potential for machine learning to accelerate electrocatalyst discovery, optimize their performance, and provide new insights into electrocatalytic mechanisms. Overall, this work offers an in-depth understanding of the current state of machine learning in electrocatalysis and its potential for future research.

Few-Layered WS2 Anchored on Co, N-Doped Carbon Hollow Polyhedron for Oxygen Evolution and Hydrogen Evolution.

Tungsten disulfide (WS2) is well known to have great potential as an electrocatalyst, but the practical application is hampered by its intrinsic inert plane and semiconductor properties. In this work, owing to a Co-based zeolite imidazole framework (ZIF-67) that effectively inhibited WS2 growth, few-layered WS2 was confined to the surface of Co, N-doped carbon polyhedron (WS2@Co9S8), with more marginal active sites and higher conductivity, which promoted efficient oxygen evolution reaction (OER) and hydrogen evolution reaction (HER). For the first time, WS2@Co9S8 was prepared by mixing in one pot of a liquid phase and calcination, and WS2 realized uniform distribution on the polyhedron surface by electrostatic adsorption in the liquid phase. The obtained hybrid catalyst exhibited excellent OER and HER catalytic activity, and the OER potential was only 15 mV at 10 mA cm-2 higher than that of noble metal oxide (RuO2). The improvement of catalytic activity can be attributed to the enhanced exposure of sulfur edge sites by WS2, the unique synergistic effect between WS2 and Co9S8 on the metal-organic framework (MOF) surface, and the effective shortening of the diffusion path by the hollow multi-channel structure. Therefore, the robust catalyst (WS2@Co9S8) prepared by a simple and efficient synthesis method in this work will serve as a highly promising bifunctional catalyst for OER and HER.

Microstructure and Mechanical Properties of W-Al2O3 Alloy Plates Prepared by a Wet Chemical Method and Rolling Process.

The uneven distribution and large size of the second phase weakens the effect of dispersion strengthening in ODS-W alloys. In this article, the W-Al2O3 composite powders were fabricated using a wet chemical method, resulting in a finer powder and uniformly dispersed Al2O3 particles in the tungsten-based alloy. The particle size of the pure tungsten powder is 1.05 µm and the particle size of W-0.2 wt.%Al2O3 is 727 nm. Subsequently, the W-Al2O3 alloy plates were successfully obtained by induction sintering and rolling processes. Al2O3 effectively refined grain size from powder-making to sintering. The micro-hardness of the tungsten alloy plates reached 512 HV0.2, which is 43.7% higher than that of pure tungsten plates. The nano-hardness reached 14.2 GPa, which is 24.1% higher than that of the pure tungsten plate; the compressive strength reached 2224 MPa, which is 37.2% higher than that of the pure tungsten.

Studies on Kinetics, Isotherms, Thermodynamics and Adsorption Mechanism of Methylene Blue by N and S Co-Doped Porous Carbon Spheres.

Heteroatom-doped carbon is widely used in the fields of adsorbents, electrode materials and catalysts due to its excellent physicochemical properties. N and S co-doped porous carbon spheres (N,S-PCSs) were synthesized using glucose and L-cysteine as carbon and heteroatom sources using a combined hydrothermal and KOH activation process. The physicochemical structures and single-factor methylene blue (MB) adsorption properties of the N,S-PCSs were then studied. The optimized N,S-PCSs-1 possessed a perfect spherical morphology with a 2-8-µm diameter and a large specific area of 1769.41 m2 g-1, in which the N and S contents were 2.97 at% and 0.88 at%, respectively. In the single-factor adsorption experiment for MB, the MB adsorption rate increased with an increase in carbon dosage and MB initial concentration, and the adsorption reached equilibrium within 2-3 h. The pseudo-second-order kinetic model could excellently fit the experimental data with a high R2 (0.9999). The Langmuir isothermal adsorption equation fitted well with the experimental results with an R2 value of 0.9618, and the MB maximum adsorption quantity was 909.10 mg g-1. The adsorption of MB by N,S-PCSs-1 was a spontaneous, endothermic, and random process based on the thermodynamics analyses. The adsorption mechanism mainly involved Van der Waals force adsorption, π-π stacking, hydrogen bonds and Lewis acid-base interactions.

Facile one-pot generation of metal oxide/hydroxide@metal-organic framework composites: highly efficient bifunctional electrocatalysts for overall water splitting.

In situ growth of Co3O4 nanocubes on the surface of Co-MOF is an effective way to adjust the surface electron structure of electrocatalysts and increase extra active sites for the OER, the HER and overall water splitting. A facile one-pot hydrothermal method can be extended to the preparation of other metal oxide/hydroxide@MOF composites.

Facile Synthesis of Antimony Tungstate Nanosheets as Anodes for Lithium-Ion Batteries.

Lithium-ion batteries (LIBs) have been widely used in the fields of smart phones, electric vehicles, and smart grids. With its opened Aurivillius structure, tungstate antimony oxide (Sb2WO6, SWO), constituted of {Sb2O2}2n+ and {WO4}2n-, is rarely investigated as an anode for lithium-ion batteries. In this work, Sb2WO6 with nanosheets morphology was successfully synthesized using a simple microwave hydrothermal method and systematically studied as an anode for lithium-ion batteries. The optimal SWO (SWO-60) exhibits a high specific discharge capacity and good rate capability. The good electrochemical performance could be ascribed to mesoporous nanosheets morphology, which is favorable for the penetration of the electrolyte and charge transportation. The results show that this nanostructured SWO is a promising anode material for LIBs.

Potentially inappropriate medications in hospitalized older patients: a cross-sectional study using the Beers 2015 criteria versus the 2012 criteria.

AIM: Polypharmacy and potentially inappropriate medications (PIMs) are prominent prescribing issues in elderly patients. The purpose of the study was to investigate the prevalence of PIMs identified by the Beers 2015 and 2012 criteria in older patients in China and identify the correlates of PIMs. METHODS: This retrospective, cross-sectional study was conducted at Peking University First Hospital. The Beers 2015 and 2012 criteria were applied to evaluate PIMs among hospitalized patients. The associations between PIM use and independent variables were analyzed by logistic regression. The differences between PIM use according to Beers 2012 and 2015 criteria were calculated using chi-squared and kappa tests. RESULTS: A total of 456 patients were analyzed; 244 (53.5%) and 204 (44.7%) patients had at least one PIM identified by the Beers 2015 and 2012 criteria, respectively. The most frequent PIMs were proton-pump inhibitors (PPIs), benzodiazepines, and benzodiazepine receptor agonists according to the Beers 2015 criteria. PIMs identified by the Beers 2015 criteria were associated with excessive polypharmacy (OR 1.864, 95% CI 1.210-2.871), a Barthel index ≤60 (OR 1.935, 95% CI 1.056-3.546), and the length of stay (OR 1.066, 95% CI 1.037-1.097). PIM use increased significantly between two criteria (chi-squared test, P<0.001), but good accordance was found between the previous and updated criteria (kappa test 0.782, P<0.001). CONCLUSION: Our study showed a high prevalence of PIM use in China, which was associated with various correlates. The Beers 2015 criteria detected significantly more PIMs than the 2012 criteria due to the inclusion of PPIs.

Vancomycin-associated acute kidney injury: A cross-sectional study from a single center in China.

OBJECTIVE: The objective of this study was to investigate the current situation of vancomycin (VAN)-associated acute kidney injury (VA-AKI) in China and identify the risk factors for VA-AKI, as well as to comprehensively examine the risk related to concurrent drug use. Further, we assessed the outcomes of patients who developed VA-AKI and the risk factors for these outcomes. Finally, we aimed to provide suggestions for improving the prevention and treatment of VA-AKI in China. METHODS: We conducted a retrospective observational study of inpatients who had been treated with VAN between January 2013 and December 2013 at Peking University First Hospital. AKI was defined as an increase in SCr of ≥0.3 mg/dl (≥26.5 µmol/l) within 48 hours or an increase to ≥1.5 times the baseline certainly or presumably within the past 7 days. VA-AKI was defined as the development of AKI during VAN therapy or within 7 days following the termination of VAN therapy. In addition, we compared patients with NO-AKI, who did not develop AKI during their hospitalization, with those with VA-AKI. RESULTS: Of the 934 patients treated with VAN during their hospital stay, 740 were included in this study. Among those excluded, 38.1% (74/194) were excluded because of a lack of data on serum creatinine (SCr). Among the included patients, 120 had confirmed VA-AKI, with an incidence of 16.2% (120/740). Multiple logistic regression analysis revealed that an elevated baseline estimated glomerular filtration rate (eGFR) (odds ratio [OR] = 1.009; p = 0.017) and concomitant vasopressor therapy (OR = 2.942; p = 0.009), nitrate use (OR = 2.869; p = 0.007), imipenem-cilastatin treatment (OR = 4.708; p = 0.000), and contrast medium administration (OR = 6.609 p = 0.005) were independent risk factors for VA-AKI; in addition, the receipt of orthopedic/trauma/burn surgery (OR = 0.3575; p = 0.011) and concomitant compound glycyrrhizin use (OR = 0.290; p = 0.017) were independent protective factors for VA-AKI. Multiple logistic regression analysis also demonstrated that among the patients who developed VA-AKI, coronary heart disease (CHD) (OR = 12.6; p = 0.006) and concomitant vasopressor therapy (OR = 15.4; p = 0.001) were independent risk factors for death. We also evaluated the factors influencing improvement of renal function. Multiple logistic regression analysis demonstrated that CHD (OR = 8.858, p = 0.019) and concomitant contrast medium administration (OR = 9.779, p = 0.005) were independent risk factors and that simultaneous ß-blocker treatment (OR = 0.124, p = 0.001) was an independent protective factor for improvement of renal function. CONCLUSION: Patients treated with VAN received insufficient monitoring of SCr and inadequate therapeutic drug monitoring. We recommend that hospitals increase their investment in clinical pharmacists. An elevated baseline eGFR and concomitant vasopressor therapy, nitrate use, imipenem-cilastatin treatment, and contrast medium administration were independent risk factors for VA-AKI; in addition, orthopedic/trauma/burn surgery and concomitant compound glycyrrhizin use were independent protective factors for VA-AKI.